| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |